Comparison between different cell kinetic variables in human breast cancer

Area of Science:

• Oncology
• Cell Biology
• Biostatistics

Background:

• Cell kinetics is crucial for predicting cancer patient outcomes and treatment response.
• Previous studies often assumed different cell kinetic variables are interchangeable, but lacked sufficient data for validation.
• This study investigates the correlation between key cell proliferation indices in a large breast cancer cohort.

Purpose of the Study:

• To verify the correlation between [3H]thymidine labelling index ([3H]dT LI), flow cytometric S phase (FCM-S), and Ki-67 immunoreactivity (Ki-67/MIB-1) in breast cancer.
• To investigate the correlation of these indices with clinical, pathological, and biological characteristics of patients and tumors.
• To determine if these cell kinetic variables can be used as alternatives to each other.

Main Methods:

• Analysis of a large series of breast cancer patients (up to 609 for Ki-67, 526 for FCM-S, 485 for [3H]dT LI).
• Parallel determination of all three cell proliferation indices ([3H]dT LI, FCM-S, Ki-67/MIB-1) on the same tumors in 330 patients.
• All determinations were conducted within National Quality Control Programmes.

Main Results:

• Very poor correlation coefficients (0.18-0.37) were observed between the different cell kinetic variables.
• Ki-67/MIB-1 and FCM-S showed significant relationships with histological type, grade, and tumor size.
• No statistically significant correlations were found for [3H]dT LI with these clinicopathological factors.

Conclusions:

• The cell kinetic variables ([3H]dT LI, FCM-S, Ki-67/MIB-1) provide distinct biological information.
• These markers cannot be considered interchangeable alternatives in breast cancer research or clinical practice.
• The findings highlight the need for careful selection of proliferation markers based on the specific biological question.